Astrazeneca PLC
AZN
|
$68.545
0.27%
1.2M
|
Health Technology
(0.0% 1d) (3.9% 1m) (-8.4% 1y) (0.0% 2d) (0.0% 3d) (-0.7% 7d) (-41.8% volume)
Earnings Calendar:
Market Cap: $ 212,519,836,372
http://astrazeneca.com
Sec Filling | Patents | 70600 employees
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
cardiovascular respiratory urea renal metabolic
add to watch list Paper trade email alert is off
Press-releases
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Just crawled : 15:00) - prnewswire.com
AZN | $68.545 0.27% 1.2M
|
Health Technology
| Email alert
Add to watchlist
LLY | $731.1 -1.99% 1M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.685 1.06% 380K
|
Health Technology
| Email alert
Add to watchlist
NVO | $123.43 0.55% 1.4M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $138.24 800
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 510
|
Health Technology
| Email alert
Add to watchlist
report reach therapeutics market
Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
million series trials program
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | $138.24 800
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $39.945 0.74% 430K
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN S | $89.63 -0.49% 190K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | $138.24 800
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
AZNCF | $138.24 800
|
Health Technology
|
| O: -3.43%
H: 6.21%
C: 6.21%
VTRS | $11.2 0.72% 1M
|
Health Technology
|
| O: -0.25%
H: 1.1%
C: -0.17%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: -0.05%
H: 0.43%
C: -0.27%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -0.35%
BHC | $8.655 0.64% 750K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -7.27%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 0.18%
H: 0.3%
C: 0.19%
eczema dermatitis set therapeutics market
Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in genome editing boost the market- Technavio
Published: 2024-04-05 (Crawled : 22:00) - prnewswire.com
AZN | $68.545 0.27% 1.2M
|
Health Technology
| Email alert
Add to watchlist
TMO | News | $543.03 0.28% 300K
|
Health Technology
| Email alert
Add to watchlist
CRBU | $3.9 -0.26% 320K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $138.24 800
|
Health Technology
| Email alert
Add to watchlist
set market
Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02 (Crawled : 08:00) - biospace.com/
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -1.18%
H: 0.34%
C: -0.22%
breast her2 license cancer application negative
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZN | $68.545 0.27% 1.2M
|
Health Technology
| Email alert
Add to watchlist
CKPT | $1.57 -1.88% 130K
|
Health Technology
| Email alert
Add to watchlist
FBIO | $1.765 -2.49% 90K
|
Health Technology
| Email alert
Add to watchlist
MBIO | $0.371 15K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $138.24 800
|
Health Technology
| Email alert
Add to watchlist
DERM | $3.58 13K
|
| Email alert
Add to watchlist
biotech financial results
Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
AZNCF | $138.24 800
|
Health Technology
|
| O: 0.89%
H: 0.78%
C: 0.78%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
BMY | $48.56 0.54% 1.8M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.12%
H: 0.25%
C: -0.63%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
abbvie set canada key market
Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AZNCF | $138.24 800
|
Health Technology
|
| O: 0.75%
H: 0.04%
C: -0.1%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: -0.08%
H: 0.33%
C: -0.53%
ARTL | $1.28 1.8K
|
Health Technology
|
| O: -4.61%
H: 4.83%
C: 3.84%
business update financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Last 48 Hours Insiders Buying
CLSD | $1.42 7.58% 100K
|
Health Technology
|
14:00
CDZI P 25000 | $2.275 1.11% 74K
|
Utilities
|
14:00
ETST P 39000 | $0.068 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.47 1.4% 6.6K
|
Finance
|
12:30
ADMQ | $0.0532 480K
|
|
10:30
AXR P 2400 | $22.26 0.41% 180
|
Finance
|
21:00
QCRH P 118 | $56.105 1.25% 11K
|
Finance
|
18:01
VUZI P 7500 | $1.245 -1.19% 140K
|
Electronic Technology
|
18:00
RMCF | $3.5501 390
|
Consumer Non-Durables
|
20:10